Purpose: Recent clinical studies raised concern of a cognitive teratogenicity of the major antiepileptic drug valproate. To investigate possible cerebral correlates, we established a forced self-application schedule by diluting valproate in the drinking water of pregnant Wistar rats.

Methods: After application of medium (MD) and high doses (HDs) with mean daily intakes of about 470 and 720 mg/kg during the entire pregnancy, we analyzed effects on offspring performance in a series of behavioral paradigms as well as brain volumetric changes by magnetic resonance imaging (MRI).

Results: While high dosages with peak serum concentrations slightly above 100 microg/ml induced early decrements in general activity and deficits in learning and memory, medium dosages led to improved watermaze performance in 30-day-old rats. MRI analyses indicated increased hippocampal volumes in the MD condition, whereas in the HD condition significantly decreased cortical and brainstem volumes were registered. Cortical volume reduction was correlated with spatial acuity in the watermaze.

Conclusions: The results indicate that effects of valproate in utero on offspring cognitive capabilities might depend on total drug load differentially affecting cerebral development during adolescence in the rat.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2008.01943.xDOI Listing

Publication Analysis

Top Keywords

dose-dependent memory
4
memory effects
4
effects cerebral
4
cerebral volume
4
volume changes
4
changes utero
4
utero exposure
4
valproate
4
exposure valproate
4
valproate rat
4

Similar Publications

Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Individuals with one copy of APOE4 exhibit greater amyloid-beta (Aβ) deposition compared to noncarriers, an effect that is even more pronounced in APOE4 homozygotes. Interestingly, APOE4 carriers not only show more AD pathology but also experience more rapid cognitive decline, particularly in episodic memory.

View Article and Find Full Text PDF

Liuwei Anshen Capsule alleviates cognitive impairment induced by sleep deprivation by reducing neuroapoptosis and inflammation.

J Ethnopharmacol

December 2024

Engineering Research Center of TCM Protection Technology and New Product Development for the Elderly Brain Health, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, 430065, China; Key Laboratory of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, China. Electronic address:

Article Synopsis
  • Cognitive dysfunction is a common issue linked to chronic insomnia, and Liuwei Anshen Capsules (LAC) have shown promise in alleviating insomnia-related complications like dementia and anxiety, although their active compounds and mechanisms are not fully understood.
  • The study aims to identify the active ingredients in LAC and their effects on cognitive impairment due to sleep deprivation, utilizing methods such as serum pharmacochemistry, network pharmacology, and experimental validation.
  • Results indicated that LAC contains 85 active ingredients, with several key targets and pathways identified, and it successfully improved cognitive function in sleep-deprived rats while regulating several proteins and inflammatory markers, suggesting its therapeutic potential.
View Article and Find Full Text PDF

Alzheimer's disease (AD), a neurological disorder, is one of the major reasons for memory loss in the world. AD is characterized by a sequela of cognitive and functional decline caused by brain cell degeneration. Paeoniflorin is a monoterpenoid glycoside found in plants of the Paeoniaceae family, which are known for their medicinal properties including dementia.

View Article and Find Full Text PDF

3-Methylmethcathinone (3-MMC) is a designer drug that belongs to the group of synthetic cathinones. The compound has been scheduled in many jurisdictions because of public health concerns associated with excessive use. To date, there are no clinical studies that have evaluated the risk profile of 3-MMC in the recreational range of low to moderate doses.

View Article and Find Full Text PDF

Eilat (EILV)/chikungunya virus (CHIKV), an insect-based chimeric alphavirus was previously reported to protect mice months after a single dose vaccination. The underlying mechanisms of host protection are not clearly defined. Here, we assessed the capacity of EILV/CHIKV to induce quick and durable protection in cynomolgus macaques.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!